AIM ImmunoTech Inc.
METHODS FOR IMPROVING EXERCISE TOLERANCE IN MYALGIC ENCEPHALOMYELITIS PATIENTS
Last updated:
Abstract:
The present invention relates to methods for treating a subject with myalgic encephalomyelitis/chronic fatigue syndrome symptoms comprising administering a target subject a pharmaceutical composition comprising a therapeutic dsRNA (tdsRNA).
Status:
Application
Type:
Utility
Filling date:
25 Nov 2019
Issue date:
3 Mar 2022